They have shorted almost 500k shares. They have to be bought back at some stage. They may of bought some of those back in the last few days. We will see when the T+4 report comes out. I'm not a seller but a buyer so I'll keep buying now while the going is so good. The question I want answered: Why would you short 500k shares with clinical trial data out in the next week. Very dangerous move.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.0¢ | $33.79K | 116.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 135924 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 9974 | 2 |
View Market Depth
| Last trade - 11.57am 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |